HF
EXAS

HRT Financial’s Exact Sciences EXAS Stock Holding History

HRT Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,100
Closed -$619K – 4064
2025
Q4 		$619K Sell
6,100
-5,600
-48% -$450K ﹤0.01% 1989
2025
Q3 		$640K Buy
+11,700
New +$585K ﹤0.01% 1749
2024
Q3 		– Sell
-5,200
Closed -$219K – 2636
2024
Q2 		$219K Buy
+5,200
New +$286K ﹤0.01% 1616
2023
Q4 		– Sell
-7,400
Closed -$504K – 2525
2023
Q3 		$504K Buy
+7,400
New +$628K 0.01% 1405
2023
Q1 		– Sell
-37,500
Closed -$1.86M – 2685
2022
Q4 		$1.86M Buy
+37,500
New +$1.53M 0.03% 633
2022
Q2 		– Sell
-9,900
Closed -$692K – 3137
2022
Q1 		$692K Buy
+9,900
New +$724K ﹤0.01% 1397

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HRT Financial's EXAS Position: Q1 2026 in Review

HRT Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 99,672 shares — an estimated $10.1M sold.

HRT Financial first reported a position in EXAS in Q2 2018 and held it in 13 quarters. The position peaked at $10.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HRT Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 99,672 Exact Sciences shares in Q1 2026, an estimated $10.1M.
  • HRT Financial first reported a position in Exact Sciences in Q2 2018 and held it in 13 quarters.
  • HRT Financial's Exact Sciences position peaked at $10.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.